ESHO

Whole body hyperthermia: 
Clinical phase II trail of combined thermochemotherapy (whole body hyperthermia plus Carboplatin/Ifosfamide) in platin-therapy refractory or relapsed ovarian cancer. 

Coordination: 

Prof. Dr. med. S. Hegewisch-Becker 
Abt. für Onkologie und Hämatologie 
Universitätsklinik Eppendorf 
Hamburg 
Tel. +49-40-42803 3971 

Whole body hyperthermia : 
Clinical phase II trail to evaluate toxicity and effect of thermochemotherapy with Mito-mycin/Ifosfamide/Cisplatin (MIC) as a third line therapy of second line (MIC-alone) pro-gressive ovarian carcinoma 

Coordination: 

Prof. Dr. med. K. Bremer 
Klinik für Hämatologie und Onkologie 
Augusta-Kranken-Anstalt 
Bochum 
Tel: +49-0234-517-2430 

Whole body hyperthermia : 
A randomized phase II/III trial comparing Carboplatin-Ifosfamide (IC)-chemotherapy vs. IC-chemotherapy combined with extreme whole body hyperthermia in patients with recurrence of epithelial ovarian carcinoma: DOLPHIN-1 

Coordination: 

Prof. Dr. med. H. Sommer 
I. Frauenklinik 
Onkologie II 
Ludwig-Maximilian-Universität 
Tel. +49-89-5160-4276